SynthesisDiagnostic and interventional radiology (Ankara, Turkey)2026
Magnetic resonance T1ρ relaxation in patients with liver fibrosis: a systematic review and meta-analysis.
Synthesis in Diagnostic and interventional radiology (Ankara, Turkey), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the diagnostic performance of T1ρ relaxation in distinguishing patients with liver fibrosis (LF) from those without.
methodsA systematic review was conducted using PubMed, EMBASE, Cochrane, and Web of Science databases up to February 2025 to identify studies assessing T1ρ for LF diagnosis.
resultsEleven studies involving 792 patients were included. T1ρ values were significantly higher in cirrhotic versus normal livers [weighted mean difference (WMD): 6.69,
conclusionT1ρ relaxation differentiates high-grade LF from normal liver tissue. CLINICAL SIGNIFICANCE: As a non-invasive imaging technique, T1ρ shows potential for use in the diagnosis and follow-up of LF and to optimize the assessment and management of chronic liver disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.